Clinical Trial KRAS G12C - Adagrasib (MRTX849) + TNO155 = Acne
Hello everyone, I have searched some terms and found no on point results, hence my new topic creation here. I have metastisised colon cancer with KRAS G12C mutation and have just started a drug trial with the new targeting drug, Adagrasib (Merati's MRTX849) combined with SHP2 inhibitor TNO155. I have 2 main side effects…